Do you want to skip to content? Skip to content
Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

Pain Management

Learn how neria™ infusion sets are recommended for Pain Management.
a woman sitting in a chair talking to a man in a chair ;

Disease Area

Chronic pain affects millions of people worldwide every year. Its presence significantly degrades the affected person's ability to function physically and emotionally, decreasing quality of life. Several standards and guidelines exist for the assessment and relief of pain – one being a recommendation by the World Health Organization (WHO) known as the “pain ladder” for pain management1.

Pain Relief

One of the most commonly prescribed class of drugs for pain is opioids, which can be classified as weak or strong. For patients with severe pain associated with serious or advanced illness, the use of opioids for palliative pain management is considered the standard of care and an effective pain reducing therapy.

Infusion Therapy

Best practice in pain management is to use the least invasive route of administration for the prescribed opioid. As a consequence patients are in most cases introduced to opioid pain management  in a short acting formulation by taking the morphine in an oral form.1 However, if the pain continues and relief is not reached, or in cases of severe pain, patients may be prescribed stronger opioids by oral administration. If patients are unable to take medication orally, then opioids may be administered by injection or continuous infusion. Subcutaneous infusion of opioids is considered preferable, as it is less invasive and may be better tolerated than intravenous infusion, and less painful than intramuscular injection.

neria™ infusion sets for Pain Management

As relief and comfort are areas of focus in pain management, especially in palliative care, the soft cannula range of neria™ infusion sets are recommended in many cases for the infusion.  These infusion sets have a disconnect feature which make the sets convenient to use during long infusion periods.

In general, however, the choice of infusion set should always be based on the health care professional’s assessment of each individual patient’s situation.

neria™ infusion sets have been tested for safe use with hydromorphone, morphine sulfate and morphine chloride for pain management2,3.

Clinical studies

Clinical studies showed that neria™ infusion sets helped minimize pain during insertion and reduced needle related traumas 4,5.

For complete clinical references, please contact ConvaTec Infusion Care at info.infusion-set@unomedical.com.

More in Infusion Therapy

Go to page

Infusion Therapy

a child smiling in water

Primary Immune Deficiency

Learn how neria™ infusion sets are used in Primary Immune Defiency treatments.

Read more

Infusion Therapy

a woman with her hair blowing in the wind

Thalassaemia

Treatments of Thalassaemia with Desferal™ and neria™ infusion sets.

Read more

Infusion Therapy

a woman sitting in a chair talking to a man in a chair

Pain management.

Learn how neria™ infusion sets are recommended for Pain Management.

Read more

Infusion Therapy

placeholder image

Parkinson's Disease.

Get an overview of how neria™ contributes to treatment of Parkinson's disease.

Read more
Go to page

1. WHO web site, www.who.int/cancer/palliative/painladder/en/
2. Drug Compatibility Study of Three Infusion Devices with Morphine Sulfate, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.
3. Drug Compatibility Study of Three Infusion Devices with Hydromorphone Hydrochloride, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.
4. Chan G.C.F, Ng D.M.W. et al, Comparison of Subcutaneous Infusion Needles for Transfusion-Dependent Thalassemia Patients by the Intrapersonal Cross-Over Assessment Model, Am.J.Hematol.76;398-404 (2004).
5. Parsons J. Infusion line preferences of patients prescribed apomorphine for complex Parkinson's disease. British Journal of Neuroscience Nursing. December 2009.Vol 5 No 12.

Visit our neria.com

Explore the universe of neria™ infusion sets.

Click here

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?